Labopharm, a Canadian pharmaceutical firm, has appointed Sylvain Guénette as chief financial officer (CFO). Guénette, a chartered accountant, joined Labopharm as controller in 2002 and was most recently vice president and corporate controller. Prior to joining Labopharm, Guénette was corporate controller at Les Systèmes Proxima Ltée and director of finance and operations at the Montreal office of Nurun. Guenette has also held various finance and accounting positions within the Quebecor Group.
On 14 March, 2011, Mark D’Souza, Lambopharm’s then CFO, was named as new president and chief executive officer (CEO). D’Souza replaced James Howard-Tripp, who resigned from Labopharm’s board of directors.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more